ImmunityBio (IBRX) Logs Third Straight Quarterly Gain

ImmunityBio, Inc. (IBRX) reported its third consecutive quarterly gain. Institutional disclosures from Q3 revealed that BlackRock had significantly narrowed the gap with Vanguard's combined holdings by adding more than three times as many shares. The stock IBRX jumped 7% to $9.44 on Wednesday.